Featured Articles

  1. Developing A Scalable RNA-LNP Drug Product For Clinical Translation 9/22/2022

    Accelerate essential process development activities with instrumentation solution allowing for highly reproducible and scalable production of RNA-LNPs.

  2. Optimizing Lipid Formulations For Targeted RNA-LNP Applications 9/13/2022

    Learn about the considerations and challenges of using ionizable lipids, including the 5 types of lipids used for RNA delivery.

  3. Process Development Considerations For RNA-LNP Therapeutics 9/13/2022

    Here, we highlight three important process considerations across the RNA-LNP manufacturing workflow which includes limit size behavior, in-line dilution and downstream tangential flow filtration (TFF).

  4. Key Stages In mRNA-Based Therapeutic Development 9/13/2022

    Learn how planning a product development strategy early on with a technology partner who has deep expertise and technical knowledge of genomic medicines can address uncertainties from the outset.

  5. Vanderbilt Moves Towards A Paperless Cell Therapy Process 8/8/2022

    The future of cell-therapy systems is here, so learn the importance of patience when implementing a paperless system today.

  6. Perfusion Filter Improves Cell Retention In Xuri Cell Expansion System 7/21/2022

    A new 1.2 μm pore size filter was validated for use in the Xuri Cell Expansion System W25, which decreased T cell loss, ultimately leading to higher T cell retention in the Xuri brand Cellbag bioreactor.

  7. Tips For Successfully Scaling Your cGMP Manufacturing 6/23/2022

    What are the specific obstacles to expanding manufacturing capacity? Cell therapy industry leaders share what to look for in a solutions provider and recommendations for navigating your road ahead.

  8. Step Up To GMP Manufacturing Or Outsource To A CDMO 6/1/2022

    Explore key factors to help you determine which strategy best suits your process, product, and team, as well as some general considerations and tips for succeeding in GMP manufacturing.

  9. Unlocking The Full Potential Of Genomic Medicine 6/1/2022

    There are two key challenges to realizing the potential of genomic medicines, but potential technological solutions are on the horizon, and we examine each.

  10. mRNA-Lipid Nanoparticles Circumvent Viral Vector Limitations 6/1/2022

    Both physical and chemical nonviral gene delivery systems for ex vivo genetic modification offer advantages over viral vectors, including smaller scale production and the low risk of immunogenicity.